Participants’ characteristics
| Age, y, median (SE); IQR | 58.1 (0.8786); 16.76 |
| Sex, n (%) | |
| Male | 132 (53) |
| Female | 116 (46.6) |
| Not answered | 1 (0.4) |
| Race, n (%) | |
| White | 214 (85.9) |
| Black or African American | 18 (7.2) |
| Asian | 6 (2.4) |
| Native Hawaiian or other Pacific Islander | 4 (1.6) |
| American Indian or Alaska Native | 2 (0.8) |
| Other | 9 (3.6) |
| Don’t know | 1 (0.4) |
| Not answered | 1 (0.4) |
| Hispanic or Latin American, n (%) | |
| No | 237 (95.2) |
| Yes | 8 (3.2) |
| Not answered | 4 (1.6) |
| Religion, n (%) | |
| Catholic Christian | 69 (27.7) |
| Other Christian | 98 (39.4) |
| Atheist | 9 (3.6) |
| Other (Hindu, Jewish, Muslim, Sikh, Buddhist, something else) | 24 (9.6) |
| Not religiously affiliated | 44 (17.7) |
| Don’t know | 1 (0.4) |
| Not answered | 5 (2.0) |
| Marital status, n (%) | |
| Married or domestic partnership | 185 (74.30) |
| Never married | 29 (11.65) |
| Divorced | 23 (9.24) |
| Widowed | 8 (3.21) |
| Separated | 3 (1.2) |
| Not answered | 1 (0.4) |
| What is the highest grade or level of education you have achieved, n (%) | |
| High school or lower | 37 (14.9) |
| Some college or college graduate | 133 (53.4) |
| Postgraduate | 77 (30.9) |
| Not answered | 2 (0.8) |
| Gross household income, n (%) | |
| <$59 999 | 90 (36.2) |
| $60 000- $99 999 | 59 (23.7) |
| $100 000 - $149 999 | 44 (17.7) |
| $>150 000 | 40 (16.1) |
| Don’t know | 8 (3.2) |
| Not answered | 8 (3.2) |
| Employment status, n (%) | |
| Working full-time (≥30 h per wk) | 69 (27.7) |
| Working part-time (<30 h per wk) | 16 (6.4) |
| Caring for home or family (not seeking paid work) | 7 (2.8) |
| Unemployed and looking for work (including laid off or furloughed) | 7 (2.8) |
| Unable to work because of illness or disability | 80 (32.1) |
| Retired | 70 (28.1) |
| Student | 6 (2.4) |
| Other, please specify | 9 (3.6) |
| Diagnosis, n (%) | |
| Leukemias (AML, ALL, other leukemias) | 42 (19.8) |
| MDS/MPN/CML | 34 (13.7) |
| Lymphoma | 55 (22.1) |
| Plasma cell disorder/multiple myeloma | 105 (42.2) |
| Other | 13 (5.2) |
| Karnofsky Performance Score | |
| <90 | 97 (39) |
| ≥90 | 145 (58.2) |
| Missing | 7 (2.8) |
| Patient regions, n (%) | |
| Midwest | 107 (43.0) |
| Northeast | 44 (17.7) |
| South | 52 (20.9) |
| West | 46 (18.5) |
| Transplant type | |
| Allogeneic HSCT | 92 (36.9) |
| Autologous HSCT | 157 (63.1) |
| HCT-CI | |
| 0 | 45 (18.1) |
| 1 | 45 (18.1) |
| 2 | 36 (14.5) |
| 3+ | 120 (48.2) |
| Unknown | 3 (1.2) |
| Conditioning intensity | |
| Myeloablative conditioning | 43 (17.3) |
| Reduced-intensive conditioning | 28 (11.2) |
| Nonmyeloablative conditioning | 12 (4.8) |
| N/A - autologous HSCT or nonmalignant | 162 (65.1) |
| Unknown | 4 (1.6) |
| Donor source, n (%) | |
| Unknown | 4 (1.6) |
| Cord blood | 6 (2.4) |
| Unrelated | 44 (17.7) |
| Related | 42 (16.9) |
| Donor type, n (%) | |
| Autologous, syngeneic | 158 (63.5) |
| HLA identical sibling | 20 (8.0) |
| Other related | 21 (8.4) |
| Well-matched unrelated | 39 (15.7) |
| Mismatched | 5 (2.0) |
| Cord blood | 6 (2.4) |
| Age, y, median (SE); IQR | 58.1 (0.8786); 16.76 |
| Sex, n (%) | |
| Male | 132 (53) |
| Female | 116 (46.6) |
| Not answered | 1 (0.4) |
| Race, n (%) | |
| White | 214 (85.9) |
| Black or African American | 18 (7.2) |
| Asian | 6 (2.4) |
| Native Hawaiian or other Pacific Islander | 4 (1.6) |
| American Indian or Alaska Native | 2 (0.8) |
| Other | 9 (3.6) |
| Don’t know | 1 (0.4) |
| Not answered | 1 (0.4) |
| Hispanic or Latin American, n (%) | |
| No | 237 (95.2) |
| Yes | 8 (3.2) |
| Not answered | 4 (1.6) |
| Religion, n (%) | |
| Catholic Christian | 69 (27.7) |
| Other Christian | 98 (39.4) |
| Atheist | 9 (3.6) |
| Other (Hindu, Jewish, Muslim, Sikh, Buddhist, something else) | 24 (9.6) |
| Not religiously affiliated | 44 (17.7) |
| Don’t know | 1 (0.4) |
| Not answered | 5 (2.0) |
| Marital status, n (%) | |
| Married or domestic partnership | 185 (74.30) |
| Never married | 29 (11.65) |
| Divorced | 23 (9.24) |
| Widowed | 8 (3.21) |
| Separated | 3 (1.2) |
| Not answered | 1 (0.4) |
| What is the highest grade or level of education you have achieved, n (%) | |
| High school or lower | 37 (14.9) |
| Some college or college graduate | 133 (53.4) |
| Postgraduate | 77 (30.9) |
| Not answered | 2 (0.8) |
| Gross household income, n (%) | |
| <$59 999 | 90 (36.2) |
| $60 000- $99 999 | 59 (23.7) |
| $100 000 - $149 999 | 44 (17.7) |
| $>150 000 | 40 (16.1) |
| Don’t know | 8 (3.2) |
| Not answered | 8 (3.2) |
| Employment status, n (%) | |
| Working full-time (≥30 h per wk) | 69 (27.7) |
| Working part-time (<30 h per wk) | 16 (6.4) |
| Caring for home or family (not seeking paid work) | 7 (2.8) |
| Unemployed and looking for work (including laid off or furloughed) | 7 (2.8) |
| Unable to work because of illness or disability | 80 (32.1) |
| Retired | 70 (28.1) |
| Student | 6 (2.4) |
| Other, please specify | 9 (3.6) |
| Diagnosis, n (%) | |
| Leukemias (AML, ALL, other leukemias) | 42 (19.8) |
| MDS/MPN/CML | 34 (13.7) |
| Lymphoma | 55 (22.1) |
| Plasma cell disorder/multiple myeloma | 105 (42.2) |
| Other | 13 (5.2) |
| Karnofsky Performance Score | |
| <90 | 97 (39) |
| ≥90 | 145 (58.2) |
| Missing | 7 (2.8) |
| Patient regions, n (%) | |
| Midwest | 107 (43.0) |
| Northeast | 44 (17.7) |
| South | 52 (20.9) |
| West | 46 (18.5) |
| Transplant type | |
| Allogeneic HSCT | 92 (36.9) |
| Autologous HSCT | 157 (63.1) |
| HCT-CI | |
| 0 | 45 (18.1) |
| 1 | 45 (18.1) |
| 2 | 36 (14.5) |
| 3+ | 120 (48.2) |
| Unknown | 3 (1.2) |
| Conditioning intensity | |
| Myeloablative conditioning | 43 (17.3) |
| Reduced-intensive conditioning | 28 (11.2) |
| Nonmyeloablative conditioning | 12 (4.8) |
| N/A - autologous HSCT or nonmalignant | 162 (65.1) |
| Unknown | 4 (1.6) |
| Donor source, n (%) | |
| Unknown | 4 (1.6) |
| Cord blood | 6 (2.4) |
| Unrelated | 44 (17.7) |
| Related | 42 (16.9) |
| Donor type, n (%) | |
| Autologous, syngeneic | 158 (63.5) |
| HLA identical sibling | 20 (8.0) |
| Other related | 21 (8.4) |
| Well-matched unrelated | 39 (15.7) |
| Mismatched | 5 (2.0) |
| Cord blood | 6 (2.4) |
AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; CML, chronic myeloid leukemia; HCT-CI, hematopoietic cell transplant-comorbidity index; IQR, interquartile range; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasms.